Karin Bauer

1.2k total citations
45 papers, 835 citations indexed

About

Karin Bauer is a scholar working on Molecular Biology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Karin Bauer has authored 45 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Hematology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Karin Bauer's work include Acute Myeloid Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Asthma and respiratory diseases (8 papers). Karin Bauer is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Asthma and respiratory diseases (8 papers). Karin Bauer collaborates with scholars based in Austria, Germany and United States. Karin Bauer's co-authors include Peter Valent, Irina Sadovnik, U. Krey, Torsten E. Reichert, Anja‐Katrin Bosserhoff, Johannes Zuber, Wolfgang R. Sperr, Gregor Eisenwort, Leonie A. Cluse and Christopher J. Ott and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and Hypertension.

In The Last Decade

Karin Bauer

45 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Bauer Austria 16 414 219 183 174 98 45 835
Aviv Madar United States 12 637 1.5× 427 1.9× 261 1.4× 148 0.9× 55 0.6× 16 1.3k
Hua Zeng China 9 542 1.3× 155 0.7× 283 1.5× 133 0.8× 77 0.8× 17 1.0k
Yang Du United States 18 473 1.1× 174 0.8× 127 0.7× 149 0.9× 36 0.4× 37 879
Philipp S. Hoppe Switzerland 18 846 2.0× 178 0.8× 394 2.2× 288 1.7× 147 1.5× 24 1.6k
Jason Walker United States 12 469 1.1× 168 0.8× 303 1.7× 86 0.5× 90 0.9× 21 936
Xiaoyu Lin China 17 737 1.8× 203 0.9× 135 0.7× 86 0.5× 53 0.5× 50 1.0k
Geoffroy Andrieux Germany 18 665 1.6× 354 1.6× 197 1.1× 77 0.4× 106 1.1× 65 1.2k
Palaniswami Rathanaswami Canada 16 358 0.9× 252 1.2× 420 2.3× 99 0.6× 234 2.4× 21 1.2k
Yuning Lu United Kingdom 19 337 0.8× 116 0.5× 390 2.1× 66 0.4× 41 0.4× 38 910

Countries citing papers authored by Karin Bauer

Since Specialization
Citations

This map shows the geographic impact of Karin Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Bauer more than expected).

Fields of papers citing papers by Karin Bauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Bauer. The network helps show where Karin Bauer may publish in the future.

Co-authorship network of co-authors of Karin Bauer

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Bauer. A scholar is included among the top collaborators of Karin Bauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Bauer. Karin Bauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauer, Karin, Alexander W. Hauswirth, Karoline V. Gleixner, et al.. (2024). BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL. American Journal of Hematology. 99(9). 1721–1731. 15 indexed citations
2.
Berger, Daniela, Karin Bauer, Christoph Kornauth, et al.. (2021). Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis. Neoplasia. 23(12). 1183–1191. 2 indexed citations
3.
Stefanzl, Gabriele, Barbara Peter, Karin Bauer, et al.. (2019). Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells. Veterinary and Comparative Oncology. 17(4). 553–561. 14 indexed citations
4.
Valent, Peter, Irina Sadovnik, Gregor Eisenwort, et al.. (2019). Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasms. Seminars in Cancer Biology. 60. 191–201. 14 indexed citations
5.
Willmann, Michael, Emir Hadzijusufovic, Olivier Hermine, et al.. (2018). Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms. Veterinary and Comparative Oncology. 17(1). 1–10. 17 indexed citations
6.
Keller, Alexandra, Bettina Wingelhofer, Barbara Peter, et al.. (2017). The JAK2 / STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma. Veterinary and Comparative Oncology. 16(1). 55–68. 18 indexed citations
7.
8.
Bauer, Karin, Martin Gosau, Jörg Reinders, et al.. (2013). Presenilin 1/ -secretase modulates P-cadherin processing and influences cell adhesion in oral squamous cell carcinoma cell lines. Carcinogenesis. 34(11). 2622–2628. 8 indexed citations
9.
Bauer, Karin, Martin Gosau, Anja‐Katrin Bosserhoff, Torsten E. Reichert, & Richard J. Bauer. (2012). P-cadherin controls the differentiation of oral keratinocytes by regulating cytokeratin 1/10 expression via C/EBP-beta-mediated signaling. Differentiation. 84(5). 345–354. 5 indexed citations
10.
Bauer, Karin, et al.. (2011). Slit-2 facilitates interaction of P-cadherin with Robo-3 and inhibits cell migration in an oral squamous cell carcinoma cell line. Carcinogenesis. 32(6). 935–943. 25 indexed citations
11.
Bauer, Richard J., et al.. (2011). The human HECA interacts with cyclins and CDKs to antagonize Wnt-mediated proliferation and chemoresistance of head and neck cancer cells. Experimental Cell Research. 318(5). 489–499. 14 indexed citations
12.
Bauer, Karin, et al.. (2009). P-cadherin induces an epithelial-like phenotype in oral squamous cell carcinoma by GSK-3beta-mediated Snail phosphorylation. Carcinogenesis. 30(10). 1781–1788. 39 indexed citations
13.
Bauer, Karin, et al.. (1997). Benazepril, an angiotensin converting enzyme inhibitor: drug interaction with salbutamol and bronchial response to histamine in normal subjects. British Journal of Clinical Pharmacology. 44(6). 573–575. 4 indexed citations
14.
Korr, Hubert, et al.. (1997). Correction factors of 3 H-β-self-absorption for quantitative autoradiography of different cell types in the brain of pre- and postnatal mice. Histochemistry and Cell Biology. 108(6). 537–541. 5 indexed citations
15.
Bauer, Karin, et al.. (1996). Fluticasone propionate 1 mg daily and beclomethasone dipropionate 2 mg daily: a comparison over 1 yr. Respiratory Medicine. 90(10). 609–617. 15 indexed citations
16.
Bauer, Karin, et al.. (1993). Pharmacodynamic effects of inhaled dry powder formulations of fenoterol and colforsin in asthma. Clinical Pharmacology & Therapeutics. 53(1). 76–83. 41 indexed citations
17.
Bauer, Karin, et al.. (1993). Assessment of β-adrenergic receptor blockade after isamoltane, a 5-HT1-receptor active compound, in healthy volunteers. Clinical Pharmacology & Therapeutics. 53(6). 675–683. 6 indexed citations
18.
Bauer, Karin, et al.. (1993). Studies on the bronchodilator, tremorogenic, cardiovascular and hypokalaemic effects of fenoterol dry powder in asthma. British Journal of Clinical Pharmacology. 36(4). 285–292. 5 indexed citations
19.
Bauer, Karin, et al.. (1991). Assessment of systemic effects of different ophthalmic β-blockers in healthy volunteers. Clinical Pharmacology & Therapeutics. 49(6). 658–664. 12 indexed citations
20.
Bauer, Karin, et al.. (1990). Pulmonary effects of long-term β2-blockade in healthy subjects: Comparative study of metoprolol OROS. American Heart Journal. 120(2). 473–477. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aviv Madar Breakdown of academic impact, for papers by Hua Zeng Breakdown of academic impact, for papers by Yang Du Breakdown of academic impact, for papers by Philipp S. Hoppe Breakdown of academic impact, for papers by Jason Walker Breakdown of academic impact, for papers by Xiaoyu Lin Breakdown of academic impact, for papers by Geoffroy Andrieux Breakdown of academic impact, for papers by Palaniswami Rathanaswami Breakdown of academic impact, for papers by Yuning Lu
Rankless by CCL
2026